PALISADE CAPITAL MANAGEMENT, LP - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is and the CUSIP is 46333XAD0. A total of 20 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$2,092,000
-2.1%
2,054,0000.0%0.05%
+11.6%
Q4 2021$2,136,000
-7.9%
2,054,000
-3.4%
0.04%
-15.7%
Q3 2021$2,319,000
-0.6%
2,127,0000.0%0.05%
-3.8%
Q2 2021$2,334,000
+1.8%
2,127,0000.0%0.05%
-1.9%
Q1 2021$2,293,000
-0.2%
2,127,0000.0%0.05%
-8.5%
Q4 2020$2,298,000
+4.3%
2,127,0000.0%0.06%
-9.2%
Q3 2020$2,203,000
-1.4%
2,127,0000.0%0.06%
-8.5%
Q2 2020$2,235,000
-44.5%
2,127,000
-44.0%
0.07%
-50.0%
Q1 2020$4,028,000
-31.1%
3,800,000
-24.0%
0.14%
-14.5%
Q4 2019$5,850,000
+16.6%
5,000,0000.0%0.17%
+8.5%
Q3 2019$5,016,000
+195.9%
5,000,000
+284.6%
0.15%
+225.5%
Q3 2018$1,695,000
-2.7%
1,300,0000.0%0.05%
-6.0%
Q2 2018$1,742,000
+13.6%
1,300,0000.0%0.05%
-3.8%
Q1 2018$1,534,000
+1.5%
1,300,0000.0%0.05%
+2.0%
Q4 2017$1,512,000
-2.2%
1,300,0000.0%0.05%
-7.3%
Q3 2017$1,546,000
-11.2%
1,300,0000.0%0.06%
-15.4%
Q2 2017$1,741,000
-55.7%
1,300,000
-58.7%
0.06%
-57.0%
Q1 2017$3,932,000
+8.2%
3,150,0000.0%0.15%
+11.0%
Q4 2016$3,634,000
-3.4%
3,150,0000.0%0.14%
+1.5%
Q3 2016$3,760,000
+11.2%
3,150,000
-3.5%
0.13%
+8.9%
Q2 2016$3,382,0003,264,0000.12%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
K2 PRINCIPAL FUND, L.P. 9,000$9,953,0000.83%
CSS LLC/IL 10,119,000$11,031,0000.46%
DeepCurrents Investment Group LLC 13,556,000$14,917,0000.45%
TENOR CAPITAL MANAGEMENT Co., L.P. 10,000,000$11,014,0000.24%
WOLVERINE ASSET MANAGEMENT LLC 28,592,000$31,218,0000.24%
HBK INVESTMENTS L P 14,616,000$15,971,0000.06%
PALISADE CAPITAL MANAGEMENT, LP 2,127,000$2,334,0000.05%
Verition Fund Management LLC 3,942,000$4,304,0000.04%
LAZARD ASSET MANAGEMENT LLC 10,037,000$10,959,0000.01%
Calamos Advisors LLC 2,423,000$2,648,0000.01%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders